MARKET

NBI

NBI

NASDAQ Biotechnology Index
IDXNASDAQ

Real-time Quotes | Nasdaq Global Index Data Service

3,796.82
+101.81
+2.76%
Closed 17:15 05/27 EDT
OPEN
3,693.35
PREV CLOSE
3,695.01
HIGH
3,796.96
LOW
3,677.65
52 WEEK HIGH
5,517.77
52 WEEK LOW
3,355.16
VOLUME
0
% RANGE
3.23%
1D
5D
1M
3M
1Y
5Y
Achilles Therapeutics Added To NASDAQ Biotechnology Index As Of Dec. 20, 2021
Achilles Therapeutics plc (NASDAQ:ACHL), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, today announced that the Company has been added to the NASDAQ Biotech Index
Benzinga · 12/20/2021 13:13
Psychedelics Company COMPASS Pathways To Join NASDAQ Biotechnology Index
Psilocybin-focused mental health care company COMPASS Pathways plc (NASDAQ: CMPS) revealed Friday that it has been selected for addition to the Nasdaq Biotechnology Index (NASDAQ: NBI), effective as of market open on Mon
Benzinga · 12/17/2021 16:15
Teknova To Join Nasdaq Biotechnology Index Effective Dec. 20, 2021
 Alpha Teknova, Inc. ("Teknova") (NASDAQ:TKNO), a leading provider of critical reagents for the development and production of biopharmaceutical products, including drug therapies, novel vaccines, and
Benzinga · 12/15/2021 23:06
Sera Prognostics Added To Nasdaq Biotechnology Index As Of Dec. 20, 2021
 Sera Prognostics Inc., The Pregnancy Company® (NASDAQ:SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today
Benzinga · 12/15/2021 13:33
The Daily Biotech Pulse: Lilly Raises Guidance, Medtronic Gets FDA Warning Letter, Decision Day For Calliditas, Genenta IPO
Here's a roundup of top developments in the biotech space over the last 24 hours.
Benzinga · 12/15/2021 13:01
ALX Oncology Added to the NASDAQ Biotechnology Index
ALX Oncology Holdings Inc., (“ALX Oncology”) (NASDAQ:ALXO) a clinical-stage immuno-oncology company developing therapies that block the CD47 checkpoint pathway, today announced that it has been selected for
Benzinga · 12/17/2020 12:03
Ovid Therapeutics Announces Addition to the Nasdaq Biotechnology Index
Ovid Therapeutics Inc. (NASDAQ:OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today announced that it has been added to the
Benzinga · 12/16/2020 12:00
No Data
Learn about the latest financial forecast of NBI. Analyze the recent business situations of NASDAQ Biotechnology Index through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
  • Performance
  • Asset Allocation
  • Dividend History
No Data
No Data
No Data
No Data